Loading...

Rapid Micro Biosystems, Inc.

RPIDNASDAQ
Healthcare
Medical - Devices
$4.08
$-0.26(-5.99%)

Rapid Micro Biosystems, Inc. (RPID) Company Profile & Overview

Explore Rapid Micro Biosystems, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Rapid Micro Biosystems, Inc. (RPID) Company Profile & Overview

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

SectorHealthcare
IndustryMedical - Devices
CEORobert G. Spignesi Jr.

Contact Information

978 349 3200
1001 Pawtucket Boulevard West, Lowell, MA, 01854

Company Facts

163 Employees
IPO DateJul 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;